| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |